[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339496-105":59,"doc-detail-339496-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","breast-cancer-clinical-outcomes-and-tumor-immune-microenvironment-cross-dialogue-of-multiple-epigenetic-modification-profiles","Breast cancer clinical outcomes and tumor immune microenvironment: cross-dialogue of multiple epigenetic modification profiles","","The study investigates how RNA methylation–related changes shape the tumor immune microenvironment and influence breast cancer clinical outcomes. RNA methylation is linked to cancer immunology, yet the roles of methylation-related genes (MRGs) in breast tumors remain unclear. Using TCGA and GEO cohorts, researchers profile genomic and transcriptional expression patterns of MRGs, define two genetic groups tied to clinicopathology, prognosis, and TME infiltration, and build an MRG model plus a nomogram to predict overall survival and therapeutic response. Risk signatures inform future clinical use.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/breast-cancer-clinical-outcomes-and-tumor-immune-microenvironment-cross-dialogue-of-multiple-epigenetic-modification-profiles/339496/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/breast-cancer-clinical-outcomes-and-tumor-immune-microenvironment-cross-dialogue-of-multiple-epigenetic-modification-profiles/339496.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What research question does the study address about breast cancer and methylation?","Question",{"text":112,"@type":113},"The study examines the role of methylation-related genes (MRGs) in breast cancer within the tumor immune microenvironment and how they relate to clinical outcomes and prognosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which data sources are used to analyze methylation-related gene expression in breast cancer?",{"text":117,"@type":113},"The analysis is based on data obtained from TCGA and GEO databases.",{"name":119,"@type":110,"acceptedAnswer":120},"How do the authors connect MRGs to prognosis and treatment-related immune features?",{"text":121,"@type":113},"They identify genetic groupings correlated with clinicopathological characteristics, prognosis, and TME cell infiltration, then build an MRG model and nomogram to predict overall survival and evaluate relationships with therapy response and TME-related measures.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339496,1791445744,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","[www.aging-us.com](www.aging-us.com) AGING 2024, Vol. 16, No. 10  \nResearch Paper  \nBreast cancer clinical outcomes and tumor immune microenvironment: cross-dialogue of multiple epigenetic modification profiles  \nChong Teng1,*, Xiaowei Song1,*, Chengjuan Fan1, Siqi Man2, Yuanyuan Hu2, Yifei Hou3, Tao Xin1  \n1 Department of Oncology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China 2Oncology, Harbin Medical University, Harbin, Heilongjiang, China  \n3School of Nursing, Harbin Medical University, Harbin, Heilongjiang, China  \n* Equal contribution  \nCorrespondence to: Tao Xin; email: [xintao1234@263.net](xintao1234@263.net), [https://orcid.org/0000-0003-2798-5068](https://orcid.org/0000-0003-2798-5068)[ ](https://orcid.org/0000-0003-2798-5068)[Keywords:](Keywords: epigenetics)[ epigenetics](Keywords: epigenetics), breast cancer, tumor metabolism, immunotherapy, methylation modification  \nReceived: July 27, 2023 Accepted: February 29, 2024 Published: May 22, 2024  \nCopyright: © 2024 Teng et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nABSTRACT  \nThe discovery of RNA methylation alterations associated with cancer holds promise for their utilization as potential biomarkers in cancer diagnosis, prognosis, and prediction. RNA methylation has been found to impact the immunological microenvironment of tumors, but the specific role of methylation-related genes (MRGs), particularly in breast cancer (BC), the most common cancer among women globally, within the tumor microenvironment remains unknown. In this study, we obtained data from TCGA and GEO databases to investigate the expression patterns of MRGs in both genomic and transcriptional domains in BC. By analyzing the data, we identified two distinct genetic groupings that were correlated with clinicopathological characteristics, prognosis, degree of TME cell infiltration, and other abnormalities in MRGs among patients. Subsequently, an MRG model was developed to predict overall survival (OS) and its accuracy was evaluated in BC patients. Additionally, a highly precise nomogram was created to enhance the practical usability of the MRG model. In low-risk groups, we observed lower TBM values and higher TIDE scores. We further explored how MRGs influence a patient’s prognosis, clinically significant characteristics, response to therapy, and the TME. These risk signatures have the potential to improve treatment strategies for BC patients and could be applied in future clinical settings. Moreover, they may also be utilized to determine prognosis and biological features in these patients.  \nINTRODUCTION  \nBreast cancer (BC) is the leading cause of tumorassociated death in females worldwide and one of the most common malignancies. It is a highly heterogeneous disease, exhibiting various characteristics across different individuals. Owing to difficulties in early diagnosis and the aggressive nature of tumor progression, a significant number of BC patients are often diagnosed at an advanced stage or with metastatic lesions [1] . As a result  \nof early detection and treatment, 5-year relative survival rate was almost 100% for BC patients diagnosed primarily in stage I, compared to only 26% for BC patients initially diagnosed in stage IV [2] . According to PAM50, BC has five subtypes (i.e., luminal A, luminal B, Her2-enriched, normal-like, and basal-like) [3] . However, it has been observed that patients with the same molecular type and similar clinical characteristics can exhibit different prognoses and responses to chemotherapy or immunotherapy [4], suggesting other subtle  \n8998  \nfactors affecting their prognosis and treatment outcome. Prognosis in BC patients can always be improved with an accurate diagnosis, detection, and treatment [5] . Hence, to","cbCaifXpf51FmTGJ","https://ap.wps.com/l/cbCaifXpf51FmTGJ","pdf",5720085,25,"English","# Abstract\n# Introduction","[{\"question\":\"What research question does the study address about breast cancer and methylation?\",\"answer\":\"The study examines the role of methylation-related genes (MRGs) in breast cancer within the tumor immune microenvironment and how they relate to clinical outcomes and prognosis.\"},{\"question\":\"Which data sources are used to analyze methylation-related gene expression in breast cancer?\",\"answer\":\"The analysis is based on data obtained from TCGA and GEO databases.\"},{\"question\":\"How do the authors connect MRGs to prognosis and treatment-related immune features?\",\"answer\":\"They identify genetic groupings correlated with clinicopathological characteristics, prognosis, and TME cell infiltration, then build an MRG model and nomogram to predict overall survival and evaluate relationships with therapy response and TME-related measures.\"}]","Breast cancer clinical outcomes and tumor immune microenvironment: cross-dialogue of multiple epigenetic modification profiles | PDF",1790030613,63,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/08fb8f05c7b40fd20bc4a0043d463284.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a6f338a47985f059e7726a7918fa4334.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b10200850e2d5e00220b9bf9cdddab24.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5316beff8fc6a4dbdf1e06a4223dd32e.webp",980,1268]